BHI News Section Archives - Page 57 of 1201

News

February 21, 2024

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

GAITHERSBURG, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a global company providing solutions that address public health threats and…

Andy

Love0

News

February 16, 2024

Fierce Biotech: NIH to invest another $515M over 4 years for long COVID research

The National Institutes of Health is investing $515 million more into long COVID research efforts, three years after launching the initiative…

Andy

Love0

News

February 15, 2024

WBJ: New CEO at Children’s National lays out her vision

By Sara Gilgore – Staff Reporter, Washington Business Journal - Feb 15, 2024 - It was her mother’s 86th birthday when Michelle Riley-Brown…

Andy

Love0

News

February 14, 2024

Children’s National performs first ever HIFU procedure on patient with cerebral palsy

In January, a team of multidisciplinary doctors performed the first case in the world of using bilateral high intensity focused ultrasound (HIFU)…

Andy

Love0

News

February 13, 2024

Waisman Biomanufacturing and RoosterBio Announce Collaboration for GMP Manufacturing of Cell and Exosome Therapies

FREDERICK, Md., Feb. 13, 2024 /PRNewswire-PRWeb/ -- Waisman Biomanufacturing, a leading contract development and manufacturing organization (CDMO) which is strategically part of…

Andy

Love0

News

February 12, 2024

Career Opportunity with BHI: Life Sciences Business Strategist

BioHealth Innovation (BHI) is an innovation intermediary that facilitates the commercialization of emerging technologies in the BioHealth Capital Region (Maryland,…

Andy

Love0

News

February 12, 2024

CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced the pricing of…

Andy

Love0

News

February 12, 2024

CityBiz+ – Biosim AI

Biosim AI, founded by a professor at the University of Maryland in College Park, has closed on $12.25 million in its bid to…

Andy

Love0

News

February 8, 2024

Amarex Celebrates Its 25th Anniversary

Germantown, MD, USA (February 07, 2024) – Amarex Clinical Research, LLC, an NSF company, announces December 2023 marked its 25th…

Andy

Love0

News

February 7, 2024

I-Mab Signs Agreement to Divest its Assets and Business Operations in China to Become Rockville-Based Biotech

ROCKVILLE, Md., Feb. 7, 2024 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB), a global biotech company exclusively focused on bringing highly differentiated immunotherapies and biologics…

Andy

Love0

BHI News Section

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

Fierce Biotech: NIH to invest another $515M over 4 years for long COVID research

WBJ: New CEO at Children’s National lays out her vision

Children’s National performs first ever HIFU procedure on patient with cerebral palsy

Waisman Biomanufacturing and RoosterBio Announce Collaboration for GMP Manufacturing of Cell and Exosome Therapies

Career Opportunity with BHI: Life Sciences Business Strategist

CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock

CityBiz+ – Biosim AI

Amarex Celebrates Its 25th Anniversary

I-Mab Signs Agreement to Divest its Assets and Business Operations in China to Become Rockville-Based Biotech

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search